Dedicated to transforming the care of people living with Rare Genetic Disorders of Obesity
We’re focused on the melanocortin-4 receptor (MC4R) pathway, which is responsible for regulating weight and hunger.
By targeting the MC4R pathway, we aim to develop therapeutics
for rare genetic disorders of obesity, including:
Leptin Receptor (LEPR)
POMC and LEPR